# Starjemza

NDC: 0143-9169
Generic name: ustekinumab-hmny
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20251027

FDA application: BLA761419

## Active ingredients

- USTEKINUMAB: 45 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9169"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9169
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b72aa27-82cc-4c1b-be43-8b50e5e3d737